On May 12th, 2020 Vivonics’ subsidiary, CranioSense, was highlighted as a Finalist for the 2020 M2D2 $200K Challenge. In a recent post on the M2D2 blog, CranioSense CEO Gordon Hirschman was interviewed about CranioSense’s development of IPASS, a device for noninvasive assessment of Intracranial Pressure (ICP) that would aid in the treatment of Traumatic Brain Injuries (TBI).
We are excited to be out of 15 finalists participating in this event, and are honored to be interviewed for the UMass Lowell M2D2 Blog.
Click here to view the M2D2 Blog Post about CranioSense and IPASS
“The Massachusetts Medical Device Development Center (M2D2) is a lifeline for the state’s smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the Umass Lowell and the UMass Medical School campuses of the University of Massachusetts.” More information about M2D2 can be found here!
To view the list of finalists, click here!
